Reduced yields in the European supply chain are the reason that lower volumes of AstraZeneca's coronavirus vaccine will initially be delivered to EU member states, according to a spokesperson for the drugmaker. Pročitaj više
| /
Reduced yields in the European supply chain are the reason that lower volumes of AstraZeneca's coronavirus vaccine will initially be delivered to EU member states, according to a spokesperson for the drugmaker. Pročitaj više